• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[苯溴马隆在高尿酸血症和痛风初始治疗中的疗效与副作用。对3899例患者的现场研究结果]

[Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].

作者信息

Matzkies F

出版信息

Fortschr Med. 1978 Aug 24;96(32):1619-21.

PMID:680625
Abstract

In a collective of 3899 out-patients, the effect of uric acid reduction of benzbromarone was tested. Ten days after beginning of treatment, a uric acid concentration of 5.1 to 5.7 mg/100 ml had been obtained. Three months after beginning of therapy, uric acid values were at 4.9 mg/100 ml, independently of age and sex. As side-effects were observed:diarrhoea in 1% (n = 41) of the treated patients, furthermore, 0,8% (n = 31) complained of gastro-intestinal trouble such as pressure over the stomach, nausea, sensation of fullness and epigastric pain. Only in 2 of the 3899 patients (0.05%) the appearance of a renal colic was observed.

摘要

在3899名门诊患者群体中,测试了苯溴马隆降低尿酸的效果。治疗开始10天后,尿酸浓度达到了5.1至5.7毫克/100毫升。治疗开始三个月后,尿酸值为4.9毫克/100毫升,与年龄和性别无关。观察到的副作用有:1%(n = 41)的接受治疗患者出现腹泻,此外,0.8%(n = 31)抱怨有胃肠道不适,如胃部压迫感、恶心、饱腹感和上腹部疼痛。在3899名患者中,仅2名(0.05%)出现肾绞痛。

相似文献

1
[Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].[苯溴马隆在高尿酸血症和痛风初始治疗中的疗效与副作用。对3899例患者的现场研究结果]
Fortschr Med. 1978 Aug 24;96(32):1619-21.
2
[Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Fortschr Med. 1976 Sep 16;94(26):1427-9.
3
[The effect of benzbromaron in gout patients with limited kidney function].
Fortschr Med. 1979 Nov 22;97(44):2057-61.
4
[Normurat (benzbromaron) in the treatment of gout].
Z Rheumatol. 1979 Sep-Oct;38(9-10):342-8.
5
[Long-term therapy with benzbromarone in uric arthritis].
Wien Med Wochenschr. 1975 Sep 19;125(28):546-8.
6
[Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].别嘌醇与苯溴马隆联合治疗高尿酸血症(作者译)
Dtsch Med Wochenschr. 1976 Oct 22;101(43):1568-70. doi: 10.1055/s-0028-1104304.
7
[Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].[使用每日50毫克和25毫克苯溴马隆治疗高尿酸血症]
Fortschr Med. 1977 Jul 21;95(27):1748-50.
8
[Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].[别嘌醇与苯溴马隆单一及联合治疗。肾脏对致石物质和胶体保护物质的排泄(作者译)]
Med Klin. 1977 Apr 15;72(15):664-8.
9
[Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
Reumatologia. 1980;18(3):287-92.
10
Benzbromarone therapy in management of refractory gout.苯溴马隆治疗难治性痛风
N Z Med J. 2005 Jun 24;118(1217):U1528.

引用本文的文献

1
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.药物相关性肾结石和结晶性肾病:病理生理学、预防和治疗。
Drugs. 2018 Feb;78(2):163-201. doi: 10.1007/s40265-017-0853-7.
2
Drug-induced renal calculi: epidemiology, prevention and management.药物性肾结石:流行病学、预防与管理
Drugs. 2004;64(3):245-75. doi: 10.2165/00003495-200464030-00003.